期刊文献+

脓毒症患者血浆可溶性颗粒膜蛋白CD62P的表达与凝血/纤溶功能关系研究 被引量:3

Correlation between the changes of plasma soluble CD62P level and coagulation/fibrinolysis in the patient with sepsis
下载PDF
导出
摘要 目的探讨脓毒症(Sepsis)患者血浆可溶性颗粒膜蛋白CD62P(s-CD62P)的表达及其与凝血/纤溶指标的关系。方法以ICU住院治疗的70例患者为研究对象,分为Sepsis组38例、全身炎症反应综合征(System-ic Inflammatory Response Syndrome,SIRS)组32例,另选取健康体检者20例作为正常对照组。分别检测其入住ICU后24h内的s-CD62P、血小板计数(PLT)、血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、D-二聚体(D-dimer)和抗凝血酶Ⅲ活性(AT-Ⅲ),并分别进行CD62P与上述凝血/纤溶指标的相关分析。结果①与正常对照组和SIRS组比较,Sepsis组s-CD62P水平明显升高(P<0.05);②与正常对照组比较,Sepsis组和SIRS组D-dimer、PT、APTT均显著升高,而PLT计数、AT-Ⅲ活性显著降低(P<0.05);③s-CD62P水平与D-dimer、PT和APTT明显正相关,而与PLT计数、AT-Ⅲ活性呈明显负相关(P<0.05)。结论脓毒症患者血浆s-CD62P水平明显升高,发生凝血/纤溶功能障碍较为常见;s-CD62P不仅是血小板活化的标志物,也是脓毒症炎症反应与凝血/纤溶功能障碍发生和发展的重要始动因素。 Objective To observe the expression of plasma soluble CD62P in sepsis patients and analyze relationship between coagulation/fibrinolysis and s-CD62P.Methods 70 critically ill patients were admitted in ICU of the Affiliated Hospital.According to diagnostic criteria of Sepsis/SIRS,the patients were divided into Sepsis group(n=38) and SIRS group(n=32),and healthy volunteers(n=20) were considered as control group.Parameters of coagulation/fibrinolysis such as PLT,PT,APTT,D-dimer and AT-Ⅲand s-CD62P were measured and analyzed within 24h admission in ICU and SOFA score of critically ill was evaluated.The relation between coagulation/fibrinolysis and s-CD62P were executed statistical analysis respectively.Results Compared with control group and SIRS group the level of s-CD62P was significantly higher in patients of sepsis group(P0.05);Compared with the control group,the level of D-dimer,PT,APTT were higher in sepsis group and SIRS group,while platelet count(PLT),the activity of AT-Ⅲ were obviously lower(P0.05);The s-CD62P level was positively correlated with TNF-α,hs-CRP,D-dimer,PT,APTT,whereas negatively correlated with PLT,AT-Ⅲ(P0.05).Conclusion The plasma s-CD62P concentration is higher in patients with sepsis,and there are dysfunctions of coagulation/fibrinolysis in patients with sepsis too.The s-CD62P is the marker of platelet activation.It is important initial factor of the occurrence and development of coagulation/fibrinolysis and sepsis/SIRS.
出处 《宁夏医学杂志》 CAS 2011年第10期911-913,共3页 Ningxia Medical Journal
关键词 脓毒症 可溶性颗粒膜蛋白CD62P 凝血 纤溶功能 Sepsis Plasma soluble CD62P Coagulation Fibrinolysis
  • 相关文献

参考文献8

二级参考文献15

  • 1American College of Chest Physician/Society of Critical Care Medicine Consensus:Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med,1992,20:864-874.
  • 2Stephan F,Hollande J,Richard O,et al.Thrombocytopenia in a surgical ICU.Chest,1999,115:1363-1370.
  • 3Rogiers P,Zhang H,Leeman M.Erythropoietin response is blunted in critically ill patients.Intensive Care Med,1997,23:159-162.
  • 4Kinasewitz GT, Yan SB, Basson B,et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ J ]. Crit Care, 2004,8 ( 2 ) : R82 - R90.
  • 5Arts DG,de Keizer NF,Vroom MB,et al. Reliability and accuracy of sequential organ failure assessment ( SOFA ) scoring [ J ]. Crit Care Med,2005,33 ( 9 ) : 1988 - 1993.
  • 6Mitchell M, Mitchell P, John C ,et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference [ J ]. Int Care Med ,2003,29:530 - 538.
  • 7Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units:results of a muhicenter, prospective study [ J ]. Crit Care Med, 1998,26( 11 ) : 1793 - 1880.
  • 8Amaral A, Opal SM, Vincent JL. Coagulation in sepsis [ J ]. Int Care Med,2004 ,30 (6) : 1032 - 1040.
  • 9Cando S,Nanzaki S,Sasaki S,et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock [ J ]. Crit Care Med, 1998,26:2005 - 2009.
  • 10Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care:results of a prospective, muhicentre study [ J ]. Int Care Med, 1999,25 (7) :686 -696.

共引文献78

同被引文献42

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部